We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Systemic Identification of Tumor Vulnerabilities

News   Mar 30, 2017 | Original story from University of Texas M. D. Anderson Cancer Center

 
Systemic Identification of Tumor Vulnerabilities

Virginia Giuliani, Ph.D.

 
 
 

RELATED ARTICLES

Clinical Trial Results: Immune Therapy Reduces Risk of Aggressive Breast Cancer Recurrence

News

An immune therapy for the most aggressive form of breast cancer can substantially reduce the risk of the disease returning, according to a clinical trial led by Professor Peter Schmid of Queen Mary University of London.

READ MORE

New Compounds Combat Multiple Viruses Including Coronavirus

News

A team has have designed compounds that block the replication of coronaviruses, as well as other disease-causing viruses, in the lab. The compounds have not yet been tested in people.

READ MORE

New Heartburn Drug on the Horizon?

News

An investigational drug capable of binding bile acids in the stomach hold potential to reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease when combined with a proton pump inhibitor (PPI), a new study suggests.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE